{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T21:04:13Z","timestamp":1791147853782,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"21","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,29]],"date-time":"2020-08-29T00:00:00Z","timestamp":1598659200000},"content-version":"vor","delay-in-days":2312,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Biological Chemistry"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1074\/jbc.m113.529529","type":"journal-article","created":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T03:41:50Z","timestamp":1397619710000},"page":"14560-14568","source":"Crossref","is-referenced-by-count":64,"title":["Structural Basis of Pharmacological Chaperoning for Human \u03b2-Galactosidase"],"prefix":"10.1016","volume":"289","author":[{"given":"Hironori","family":"Suzuki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umeharu","family":"Ohto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Higaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Mena-Barrag\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matilde","family":"Aguilar-Moncayo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Ortiz Mellet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Nanba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Garcia Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshiyuki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1074\/jbc.M113.529529_bib1","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0016-5085(69)80104-6","article-title":"On \u03b2-galactosidase activity","volume":"56","author":"Alpers","year":"1969","journal-title":"Gastroenterology"},{"key":"10.1074\/jbc.M113.529529_bib2","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/0003-2697(72)90147-9","article-title":"Human small intestine-galactosidases: specific assay of three different enzymes","volume":"47","author":"Asp","year":"1972","journal-title":"Anal. Biochem"},{"key":"10.1074\/jbc.M113.529529_bib3","doi-asserted-by":"crossref","first-page":"6772","DOI":"10.1016\/S0021-9258(19)43421-2","article-title":"The purification and properties of \u03b2-galactosidase from bovine testes","volume":"248","author":"Distler","year":"1973","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.529529_bib4","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0925-4439(99)00075-7","article-title":"Molecular basis of GM1 gangliosidosis and Morquio disease, type B: structure-function studies of lysosomal \u03b2-galactosidase and the non-lysosomal \u03b2-galactosidase-like protein","volume":"1455","author":"Callahan","year":"1999","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1074\/jbc.M113.529529_bib5","first-page":"1091","article-title":"Human \u03b2-galactosidase gene mutations in Morquio B disease","volume":"49","author":"Oshima","year":"1991","journal-title":"Am. J. Hum. Genet"},{"key":"10.1074\/jbc.M113.529529_bib6","first-page":"435","article-title":"Human \u03b2-galactosidase gene mutations in GM1-gangliosidosis: a common mutation among Japanese adult\/chronic cases","volume":"49","author":"Yoshida","year":"1991","journal-title":"Am. J. Hum. Genet"},{"key":"10.1074\/jbc.M113.529529_bib7","series-title":"The Online Metabolic and Molecular Bases of Inherited Disease, Chapter 151","article-title":"\u03b2-Galactosidase deficiency (\u03b2-galactosidosis): GM1-gangliosidosis and Morquio B disease","author":"Suzuki","year":"2013"},{"key":"10.1074\/jbc.M113.529529_bib8","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/humu.21516","article-title":"Chemical chaperone therapy: chaperone effect on mutant enzyme and cellular pathophysiology in \u03b2-galactosidase deficiency","volume":"32","author":"Higaki","year":"2011","journal-title":"Hum. Mutat"},{"key":"10.1074\/jbc.M113.529529_bib9","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1002\/humu.21031","article-title":"GM1 gangliosidosis and Morquio B disease: expression analysis of missense mutations affecting the catalytic site of acid \u03b2-galactosidase","volume":"30","author":"Hofer","year":"2009","journal-title":"Hum. Mutat"},{"key":"10.1074\/jbc.M113.529529_bib10","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1146\/annurev.med.57.110104.115650","article-title":"Enzyme replacement for lysosomal diseases","volume":"57","author":"Brady","year":"2006","journal-title":"Annu. Rev. Med"},{"key":"10.1074\/jbc.M113.529529_bib11","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1146\/annurev-genom-090711-163739","article-title":"Enzyme replacement therapy for lysosomal diseases: lessons from 20 years of experience and remaining challenges","volume":"13","author":"Desnick","year":"2012","journal-title":"Annu. Rev. Genomics Hum. Genet"},{"key":"10.1074\/jbc.M113.529529_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/emmm.200900036","article-title":"Treating lysosomal storage diseases with pharmacological chaperones: from concept to clinics","volume":"1","author":"Parenti","year":"2009","journal-title":"EMBO Mol. Med"},{"key":"10.1074\/jbc.M113.529529_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/j.1651-2227.2008.00656.x","article-title":"Substrate reduction therapy","volume":"97","author":"Platt","year":"2008","journal-title":"Acta Paediatr"},{"key":"10.1074\/jbc.M113.529529_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1515\/BC.2008.009","article-title":"A counterintuitive approach to treat enzyme deficiencies: use of enzyme inhibitors for restoring mutant enzyme activity","volume":"389","author":"Fan","year":"2008","journal-title":"Biol. Chem"},{"key":"10.1074\/jbc.M113.529529_bib15","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1016\/j.chembiol.2011.10.012","article-title":"The molecular basis of pharmacological chaperoning in human \u03b1-galactosidase","volume":"18","author":"Guce","year":"2011","journal-title":"Chem. Biol"},{"key":"10.1074\/jbc.M113.529529_bib16","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.braindev.2012.12.002","article-title":"Chaperone therapy update: Fabry disease, GM1-gangliosidosis and Gaucher disease","volume":"35","author":"Suzuki","year":"2013","journal-title":"Brain Dev"},{"key":"10.1074\/jbc.M113.529529_bib17","doi-asserted-by":"crossref","first-page":"6514","DOI":"10.1039\/c2cc32065g","article-title":"Tuning glycosidase inhibition through aglycone interactions: pharmacological chaperones for Fabry disease and GM1 gangliosidosis","volume":"48","author":"Aguilar-Moncayo","year":"2012","journal-title":"Chem. Commun"},{"key":"10.1074\/jbc.M113.529529_bib18","doi-asserted-by":"crossref","first-page":"15912","DOI":"10.1073\/pnas.2536657100","article-title":"Chemical chaperone therapy for brain pathology in GM1-gangliosidosis","volume":"100","author":"Matsuda","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.529529_bib19","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1016\/S0968-0896(02)00005-6","article-title":"Chemical modification of the \u03b2-glucocerebrosidase inhibitor N-octyl-\u03b2-valienamine: synthesis and biological evaluation of 4-epimeric and 4-O-(\u03b2-d-galactopyranosyl) derivatives","volume":"10","author":"Ogawa","year":"2002","journal-title":"Bioorg. Med. Chem"},{"key":"10.1074\/jbc.M113.529529_bib20","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1038\/mt.2012.263","article-title":"A bicyclic 1-deoxygalactonojirimycin derivative as a novel pharmacological chaperone for GM1 gangliosidosis","volume":"21","author":"Takai","year":"2013","journal-title":"Mol. Ther"},{"key":"10.1074\/jbc.M113.529529_bib21","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1039\/c1ob05234a","article-title":"Bicyclic (galacto)nojirimycin analogues as glycosidase inhibitors: effect of structural modifications in their pharmacological chaperone potential towards \u03b2-glucocerebrosidase","volume":"9","author":"Aguilar-Moncayo","year":"2011","journal-title":"Org. Biomol. Chem"},{"key":"10.1074\/jbc.M113.529529_bib22","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1517\/13543776.2011.569162","article-title":"Pharmacological chaperone therapy for Gaucher disease: a patent review","volume":"21","author":"Benito","year":"2011","journal-title":"Expert Opin. Ther. Pat"},{"key":"10.1074\/jbc.M113.529529_bib23","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1002\/cbic.200900442","article-title":"Chaperone activity of bicyclic nojirimycin analogues for Gaucher mutations in comparison with N-(n-nonyl)deoxynojirimycin","volume":"10","author":"Luan","year":"2009","journal-title":"ChemBioChem"},{"key":"10.1074\/jbc.M113.529529_bib24","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1074\/jbc.M111.293795","article-title":"Crystal structure of human \u03b2-galactosidase: structural basis of GM1 gangliosidosis and morquio B diseases","volume":"287","author":"Ohto","year":"2012","journal-title":"J. Biol. Chem"},{"key":"10.1074\/jbc.M113.529529_bib25","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1002\/cbic.200800451","article-title":"Molecular basis for \u03b2-glucosidase inhibition by ring-modified calystegine analoges","volume":"9","author":"Aguilar","year":"2008","journal-title":"ChemBioChem"},{"key":"10.1074\/jbc.M113.529529_bib26","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.carres.2012.12.010","article-title":"Concise syntheses of potent chaperone drug candidates, N-octyl-4-epi-\u03b2-valinenamine (NOEV) and its 6-deoxy derivative, from (+)-proto-quercitol","volume":"368","author":"Kuno","year":"2013","journal-title":"Carbohydr. Res"},{"key":"10.1074\/jbc.M113.529529_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1107\/S1744309111047920","article-title":"Expression, purification, crystallization and preliminary X-ray crystallographic analysis of human \u03b2-galactosidase","volume":"68","author":"Usui","year":"2012","journal-title":"Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun"},{"key":"10.1074\/jbc.M113.529529_bib28","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0076-6879(97)76066-X","article-title":"Processing of X-ray diffraction data collected in oscillation mode","volume":"276","author":"Otwinowski","year":"1997","journal-title":"Methods Enzymol"},{"key":"10.1074\/jbc.M113.529529_bib29","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1107\/S0907444994003112","article-title":"The CCP4 suite: programs for protein crystallography","volume":"50","author":"Collaborative Computational Project, Number 4","year":"1994","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M113.529529_bib30","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1107\/S0907444904019158","article-title":"Coot: model-building tools for molecular graphics","volume":"60","author":"Emsley","year":"2004","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M113.529529_bib31","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1107\/S0907444996012255","article-title":"Refinement of macromolecular structures by the maximum-likelihood method","volume":"53","author":"Murshudov","year":"1997","journal-title":"Acta Crystallogr. D Biol. Crystallogr"},{"key":"10.1074\/jbc.M113.529529_bib32","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1016\/S0009-9120(98)00107-6","article-title":"Biochemical studies on leukocyte and fibroblast human \u03b2-galactosidase","volume":"32","author":"Coelho","year":"1999","journal-title":"Clin. Biochem"},{"key":"10.1074\/jbc.M113.529529_bib33","doi-asserted-by":"crossref","first-page":"15428","DOI":"10.1073\/pnas.192582899","article-title":"Chemical chaperones increase the cellular activity of N370S \u03b2-glucosidase: a therapeutic strategy for Gaucher disease","volume":"99","author":"Sawkar","year":"2002","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1074\/jbc.M113.529529_bib34","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1021\/jo991242o","article-title":"Generalized anomeric effect in action: synthesis and evaluation of stable reducing indolizidine glycomimetics as glycosidase inhibitors","volume":"65","author":"D\u00edaz P\u00e9rez","year":"2000","journal-title":"J. Org. Chem"},{"key":"10.1074\/jbc.M113.529529_bib35","doi-asserted-by":"crossref","first-page":"8527","DOI":"10.1002\/chem.201200279","article-title":"sp2-Iminosugar O-, S-, and N-glycosides as conformational mimics of \u03b1-linked disaccharides: implications for glycosidase inhibition","volume":"18","author":"S\u00e1nchez-Fern\u00e1ndez","year":"2012","journal-title":"Chem. Eur. J"},{"key":"10.1074\/jbc.M113.529529_bib36","first-page":"7","article-title":"Chaperone therapy for neuronopathic lysosomal diseases: competitive inhibitors as chemical chaperones for enhancement of mutant enzyme activities","volume":"3","author":"Suzuki","year":"2009","journal-title":"Perspect. Med. Chem"},{"key":"10.1074\/jbc.M113.529529_bib37","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1107\/S0907444911007281","article-title":"Presenting your structures: the CCP4mg molecular-graphics software","volume":"67","author":"McNicholas","year":"2011","journal-title":"Acta Crystallogr. D Biol. Crystallogr"}],"container-title":["Journal of Biological Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820386610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0021925820386610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1074\/jbc.M113.529529","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,12,17]],"date-time":"2021-12-17T01:16:28Z","timestamp":1639703788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0021925820386610"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,5]]},"references-count":37,"journal-issue":{"issue":"21","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S0021925820386610"],"URL":"https:\/\/doi.org\/10.1074\/jbc.m113.529529","relation":{},"ISSN":["0021-9258"],"issn-type":[{"value":"0021-9258","type":"print"}],"subject":[],"published":{"date-parts":[[2014,5]]}}}